Literature DB >> 1569698

In vitro particulate adherence to fibronectin: correlation with in vivo particulate adherence to sites of bladder injury.

W A See1, D P Rohlf, S A Crist.   

Abstract

This study examined the role of fibronectin in promoting particulate attachment to sites of urothelial injury. Variables influencing adherence of the rat transitional carcinoma cell line 4909 and "non-cellular" styrene-divinylbenzene microspheres to fibronectin were studied in an in vitro system. A soluble synthetic peptide fragment (Gly-Arg-Gly-Asp-Ser [GRGDS]) duplicating the receptor binding domain of fibronectin (RGD) was used to determine whether cell adherence could be inhibited by fibronectin receptor blockade. In vitro findings were correlated with an in vivo assay of both cellular and non-cellular particulate adherence to injured urothelium. Time, plated cell density, substrate concentration, GRGDS concentration, and cell viability, were all found to be significant independent variables influencing in vitro cellular adherence (p less than 0.0001). Receptor blockade with GRGDS significantly decreased in vitro tumor cell adherence to fibronectin. In vitro microsphere binding increased as a direct function of fibronectin concentration but was not time dependent (p less than 0.0001 and p = 0.14 for fibronectin concentration and time respectively). The in vivo adherence of both tumor cells and microspheres was significantly increased in injured bladders compared to controls (p less than 0.01). Receptor blockade with GRGDS failed to inhibit in vivo cell adherence to sites of urothelial injury. Microspheres proved to be competitive inhibitors of cellular adherence in competitive binding assays. In vitro microsphere binding demonstrated a pH dependence with maximal binding at pH 7.2. These data suggest that in vitro tumor cell adherence to fibronectin differs from in vivo tumor cell adherence to sites of urothelial injury. Manipulations which inhibit in vitro adherence, specifically fibronectin receptor blockade and cell death, fail to effect in vivo binding to the extreme that non-cellular particulate appears to bind to the same site, and with similar affinity, as cellular particles.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569698     DOI: 10.1016/s0022-5347(17)37585-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial.

Authors:  Edward M Messing; Catherine M Tangen; Seth P Lerner; Deepak M Sahasrabudhe; Theresa M Koppie; David P Wood; Philip C Mack; Robert S Svatek; Christopher P Evans; Khaled S Hafez; Daniel J Culkin; Timothy C Brand; Lawrence I Karsh; Jeffrey M Holzbeierlein; Shandra S Wilson; Guan Wu; Melissa Plets; Nicholas J Vogelzang; Ian M Thompson
Journal:  JAMA       Date:  2018-05-08       Impact factor: 56.272

2.  Specific binding of bacillus Calmette-Guérin to urothelial tumor cells in vitro.

Authors:  B Schneider; A Thanhäuser; D Jocham; H Loppnow; E Vollmer; J Galle; H D Flad; A J Ulmer; A Böhle
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

3.  Inhibition of bladder tumor cell implantation in cauterized urothelium, without inhibition of healing, by a fibronectin-related peptide (GRGDS).

Authors:  L M Hyacinthe; T W Jarrett; C S Gordon; E D Vaughan; G F Whalen
Journal:  Ann Surg Oncol       Date:  1995-09       Impact factor: 5.344

4.  Future Research Directions in the Design of Versatile Extracellular Matrix in Tissue Engineering.

Authors:  Agustina Setiawati; Huong Thanh Nguyen; Yeongheon Jung; Kwanwoo Shin
Journal:  Int Neurourol J       Date:  2018-07-31       Impact factor: 2.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.